Doo Hyun Chung

Overview

Best Publications

• Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

  Sae-Won Han;Tae-You Kim;Pil Gyu Hwang;Soohyun Jeong

  991
  Citations

• STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells

  Joo Eun Jung;Hyun Gyu Lee;Ik Hyun Cho;Doo Hyun Chung

  557
  Citations

• Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.

  June Koo Lee;Junehawk Lee;Sehui Kim;Soyeon Kim

  494
  Citations

• Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

  Sae-Won Han;Tae-You Kim;Yoon Kyung Jeon;Pil Gyu Hwang

  354
  Citations

• Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis

  E H Kang;E B Lee;E B Lee;K C Shin;C H Im

  281
  Citations

• Tumor-associated macrophages enhance tumor hypoxia and aerobic glycolysis

  Hoibin Jeong;Sehui Kim;Beom-Ju Hong;Chan-Ju Lee

  267
  Citations

• Correlation between the Size of the Solid Component on Thin-Section CT and the Invasive Component on Pathology in Small Lung Adenocarcinomas Manifesting as Ground-Glass Nodules

  Kyung Hee Lee;Jin Mo Goo;Jin Mo Goo;Sang Joon Park;Sang Joon Park;Jae Yeon Wi

  266
  Citations

• Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration

  Chan Young Ock;Bhumsuk Keam;Sehui Kim;Ju Seog Lee

  265
  Citations

• High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.

  Heounjeong Go;Yoon Kyung Jeon;Hyo Jin Park;Sook-Whan Sung

  250
  Citations

• PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.

  Hyo Jin Park;Joon Seok Park;Joon Seok Park;Yun Hee Jeong;Jimin Son

  234
  Citations

• Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.

  Moon Young Kim;Jaemoon Koh;Sehui Kim;Sehui Kim;Heounjeong Go

  224
  Citations

• Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma

  Jake June-Koo Lee;Seongyeol Park;Hansol Park;Sehui Kim

  220
  Citations

• Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status.

  Su Jin Shin;Yoon Kyung Jeon;Pil Jong Kim;Yong Mee Cho

  220
  Citations

• Mechanisms of Acquired Resistance to AZD9291: A Mutation-Selective, Irreversible EGFR Inhibitor.

  Tae Min Kim;Tae Min Kim;Ahnah Song;Dong-Wan Kim;Dong-Wan Kim;Soyeon Kim

  220
  Citations

• Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.

  Sehui Kim;Moon Young Kim;Jaemoon Koh;Jaemoon Koh;Heounjeong Go

  219
  Citations

• Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability

  Hyun Jin Shin;Kwan Hyuck Baek;Ae Hwa Jeon;Moon Taek Park

  215
  Citations

• Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status.

  Jaemoon Koh;Heounjeong Go;Bhumsuk Keam;Moon Young Kim

  210
  Citations

• Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy-resistant non-small cell lung cancer†

  Sae-Won Han;Pil Gyu Hwang;Doo Hyun Chung;Dong-Wan Kim

  209
  Citations

• Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.

  Hyun Ju Lee;Young Tae Kim;Chang Hyun Kang;Binsheng Zhao

  205
  Citations

• Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer

  Soyeon Kim;Tae Min Kim;Tae Min Kim;Dong Wan Kim;Dong Wan Kim;Heounjeong Go

  200
  Citations

• Palliative chemotherapy for pulmonary pleomorphic carcinoma.

  Hyun Mi Bae;Hye Sook Min;Se Hoon Lee;Se Hoon Lee;Dong Wan Kim;Dong Wan Kim

  198
  Citations

• Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer.

  Jeong Ok Lee;Tae Min Kim;Tae Min Kim;Se Hoon Lee;Se Hoon Lee;Dong Wan Kim;Dong Wan Kim

  189
  Citations

• Psat1-Dependent Fluctuations in α-Ketoglutarate Affect the Timing of ESC Differentiation.

  In Young Hwang;Sojung Kwak;Sangho Lee;Sangho Lee;Hyunsoo Kim

  182
  Citations